Madrigal Pharmaceuticals receives three new resmetirom patents
Go back to Madrigal Pharmaceuticals receives three new resmetirom patents| (NASDAQ: MDGL) | Delayed: 543.35 +5.70 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $537.65 | 52 Week High | $18.24 | |||
| Open | $537.65 | 52 Week Low | $6.60 | |||
| Day High | $549.04 | P/E | N/A | |||
| Day Low | $526.61 | EPS | $0.00 | |||
| Volume | 160,513 | |||||

